Inspecs GroupINPEF 52 Days Payable is 89.91 as of Dec. 2025, which is 1% below its 10-year median of 90.47. GuruFocus rates INPEF with a GF Score™ of 52/100 and a GF Value™ of $0.65. The stock has 6 warning signs investors should review. Among 795 Medical Devices & Instruments companies, Inspecs Group ranks better than 62.26% on this metric.
The historical rank and industry rank for Inspecs Group's Days Payable or its related term are showing as below:
INPEF'
s Days Payable Range Over the Past 10 Years
Min: 65.37 Med: 90.47 Max: 188.66
Current: 92.72
During the past 10 years, Inspecs Group's highest Days Payable was 188.66. The lowest was 65.37. And the median was 90.47.
INPEF's Days Payable is ranked better than 62.26% of 795
companies
in the Medical Devices & Instruments industry
Industry Median: 67.87
vs INPEF: 92.72
Inspecs Group's Days Payable
declined
from Dec. 2024 (101.01) to Dec. 2025 (89.91).
It may suggest that Inspecs Groupaccelerated paying its suppliers.
Inspecs Group Days Payable Related Terms
Inspecs Group Days Payable Historical Data
* Premium members only.
The historical data trend for Inspecs Group's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Inspecs Group's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Inspecs Group Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Inspecs Group's Days Payable distribution charts can be found below:
* The bar in red indicates where Inspecs Group's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Inspecs Group's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Inspecs Group (INPEF) has a Days Payable of 89.91 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Inspecs Group and its competitors. This is near median its historical median of 90.47. Over the past decade, Inspecs Group's Days Payable has ranged from 65.37 to 188.66. According to the industry distribution chart, Inspecs Group ranks #300 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 37.7%.
Is Inspecs Group's Days Payable too high?
Inspecs Group's current Days Payable of 89.91 is near median its 10-year median of 90.47. Over the past 10 years, this metric has ranged from a low of 65.37 to a high of 188.66. The Medical Devices & Instruments industry median Days Payable is 67.87. Inspecs Group's value of 89.91 is 32.5% above this industry median. Based on the distribution chart, Inspecs Group ranks #300 out of 795 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Inspecs Group has a GF Score™ of 52/100, reflecting its overall financial health beyond just this single metric.
How does Inspecs Group's Days Payable compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Inspecs Group ranks #300 out of 795 companies for Days Payable. This puts Inspecs Group in the upper half of its industry. The industry median Days Payable is 67.87. Inspecs Group's value of 89.91 is 32.5% above this benchmark. Historically, Inspecs Group's own Days Payable has ranged from 65.37 to 188.66 over the past decade. While the company's 10-year median is 90.47 vs. the industry median of 67.87, Inspecs Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 67.87, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Inspecs Group's current Days Payable of 89.91 is 32.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Inspecs Group and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 67.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Inspecs Group's current Days Payable is 89.91, which is near median its own 10-year median of 90.47. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Inspecs Group stock overvalued right now?
Inspecs Group (INPEF) has a current Days Payable of 89.91. The stock's GF Value™ is $0.65, compared to a current price of $1.08 — trading 66.2% above its estimated fair value. The current Days Payable is 89.91, which is near median its 10-year median of 90.47 and 32.5% above the Medical Devices & Instruments industry median of 67.87. Inspecs Group's overall GF Score™ is 52/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Inspecs Group (INPEF), the current Days Payable is 89.91 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Inspecs Group (INPEF) Overvalued in 2026?
Based on GuruFocus' analysis, Inspecs Group stock appears to be overvalued.
The current stock price of $1.08 is trading 66.2% above its estimated GF Value™ of $0.65.
Key valuation signals for INPEF:
Days Payable: 89.91 (near median its 10-year median of 90.47)
GF Value™: $0.65 vs. price of $1.08 (66.2% above fair value)
Industry Position: 32.5% above the Medical Devices & Instruments median (#300 of 795)
No single metric tells the full story. See the INPEF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Inspecs Group PLC is a designer and manufacturer of eyewear frames and accessories. The customers of the company include optical and Non-optical retailers, distributors, and independent opticians. The company operations are spread across the United Kingdom, Europe (excluding the UK), South America, North America, Asia, Africa, and Australia. Its eyewear brands include Superdry, Titanflex, O'Neill, Brendel, Humphreys, Marc O'Polo, and among others. The reporting segments of the company are Frames and Optics product distribution which derives maximum revenue, and Manufacturing includes OEM and manufacturing distribution segment.
52GF Score
Get the complete analysis for INPEF
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
INPEF has been successfully added to your 
